White Paper
Cancer-Related Technologies Have Changed a Lot. So Should Cancer Screening.
February 15, 2023
Featured Experts: Dana Goldman, PhD, Darius Lakdawalla, PhD, Karen Van Nuys, PhD
Research
All Research Featured Research
Perspective
The Cantwell-Grassley PBM Bill Is Much Needed But More Can Be Done
July 12, 2022
Featured Experts: Neeraj Sood, PhD, Karen Van Nuys, PhD
Perspective
PBMs Are Inflating the Cost of Generic Drugs. They Must Be Reined In
July 5, 2022
Featured Experts: Erin Trish, PhD, Karen Van Nuys, PhD
White Paper
U.S. Consumers Overpay for Generic Drugs
May 31, 2022
Featured Experts: Erin Trish, PhD, Karen Van Nuys, PhD
Comment Letter
Comments to the Federal Trade Commission on Pharmacy Benefit Managers
May 25, 2022
Featured Experts: Geoffrey Joyce, PhD, Darius Lakdawalla, PhD, Karen Mulligan, PhD, Neeraj Sood, PhD, Erin Trish, PhD, Karen Van Nuys, PhD
Perspective
Who Is Really Driving Up Insulin Costs?
April 18, 2022
Featured Experts: Karen Van Nuys, PhD, Erin Trish, PhD, Neeraj Sood, PhD
Perspective
Middlemen, Not Drug Companies, Are Pushing Up Insulin Prices, and Congress Doesn’t Have the Right Plan to Fight Back
November 19, 2021
Featured Experts: Karen Van Nuys, PhD, Neeraj Sood, PhD
Journal Article
Estimation of the Share of Net Expenditures on Insulin Captured by US Manufacturers, Wholesalers, Pharmacy Benefit Managers, Pharmacies, and Health Plans From 2014 to 2018
November 5, 2021
Featured Experts: Karen Van Nuys, PhD, Neeraj Sood, PhD
News
More than Half of Insulin Expenditures Going to Middlemen, New USC Schaeffer Study Finds
November 5, 2021
Featured Experts: Karen Van Nuys, PhD, Neeraj Sood, PhD
Data Visualization
Untangling the Price of Insulin
November 5, 2021
Featured Experts: Karen Van Nuys, PhD, Neeraj Sood, PhD
White Paper
Reducing Racial Disparities in Early Cancer Diagnosis With Blood-Based Tests
July 12, 2021
Featured Experts: Alison Sexton Ward, PhD, Karen Van Nuys, PhD, Darius Lakdawalla, PhD
Journal Article
Comparison of Spending on Common Generic Drugs by Medicare vs Costco Members
July 7, 2021
Featured Experts: Erin Trish, PhD, Karen Van Nuys, PhD, Geoffrey Joyce, PhD
White Paper
Impacts of First-in-Class Drug Approvals on Future in-Class Innovation
May 20, 2021
Featured Experts: Alison Sexton Ward, PhD, Karen Van Nuys, PhD, Darius Lakdawalla, PhD
Perspective
Don’t Make Surgery Another COVID Casualty
April 29, 2021
Featured Experts: Karen Van Nuys, PhD, Darius Lakdawalla, PhD
Case Study
Schaeffer Solutions: Reining in Prescription Drug Costs
April 24, 2021
Featured Experts: Neeraj Sood, PhD, Karen Van Nuys, PhD, Darius Lakdawalla, PhD, Dana Goldman, PhD, Erin Trish, PhD
Perspective
Insurer Formularies Complicate the Adoption of Biosimilar Cancer Therapies
April 8, 2021
Featured Experts: Alice Chen, PhD, Karen Van Nuys, PhD
News
Minimally Invasive Surgeries Offer Strategies for Hospitals to Create Surge Capacity
March 17, 2021
Featured Experts: Darius Lakdawalla, PhD, Karen Van Nuys, PhD
White Paper
Reassessing the Value of Minimally Invasive Technologies in the Era of COVID-19
March 17, 2021
Featured Experts: Darius Lakdawalla, PhD, Dana Goldman, PhD, Karen Van Nuys, PhD
Perspective
Yes, We Need a Vaccine to Control COVID-19. But We Need New Treatments, Too.
August 5, 2020
Featured Experts: Karen Mulligan, PhD, Karen Van Nuys, PhD
- ← Previous
- 1
- 2
- 3
- 4
- Next →